Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.15
Bid: 17.80
Ask: 18.50
Change: -0.30 (-1.63%)
Spread: 0.70 (3.933%)
Open: 18.45
High: 0.00
Low: 0.00
Prev. Close: 18.45
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Sale of NGSoft

1 Mar 2021 07:00

RNS Number : 6021Q
BATM Advanced Communications Ld
01 March 2021
 

LEI: 213800FLQUB9J289RU66

1 March 2021

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Update on Sale of NGSoft

 

Further to the Group's announcement of 12 January 2021, BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has exercised its option to sell NG Soft Ltd. ("NGSoft"), a subsidiary of the Group, for NIS 105.1m (approximately $33m) to Aztek Technologies (1984) Ltd., a provider of ICT cloud services in Israel and a portfolio company of SKY Fund (the "Buyer").

 

The Group and the Buyer have entered into a share purchase agreement pursuant to which the Buyer will purchase the entire issued share capital of NGSoft for a total consideration of NIS 105.1m (c. $33m), of which the Group will receive a total of NIS 93.7m (c. $29m) in cash. The Group's consideration includes a NIS 15.5m loan repayment from NGSoft and a NIS 2.1m dividend payment, which will be received prior to completion, and the remaining NIS 76.1m will be received on completion. Certain employees of NGSoft will receive the balance of NIS 11.4m through cash out of their employee options and rights on completion. Completion, which is subject to the receipt of approval from the Israel Competition Authority, is expected to occur by the end of March 2021.

 

The Group intends to invest the proceeds of the sale to strengthen its innovation and commercialisation engine organically and through acquisition to enable the Group to accelerate its core activities - in particular, in network function virtualisation ("NFV") and molecular diagnostics. The Board of BATM believes these areas offer transformational growth opportunities in the short- to medium-term. In addition, the disposal of NGSoft, combined with the increased contribution to Group revenue from molecular diagnostics and NFV, will support the anticipated improvement in gross margin for 2021.

 

NGSoft is a software and digital services company that provides creative digital and technology solutions. Its development activities do not include any of the Group's NFV or cyber solutions. In 2020, NGSoft generated a profit before tax of $2.4m and as at 31 December 2020 it had gross assets of $22.5m.

 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to be, once again, generating value from the sale of a part of our portfolio that is non-core to our future. We will be able to use the proceeds from this transaction to accelerate the areas of our business that we believe will provide transformational growth opportunities. This follows an extremely successful 2020, with significant strategic progress in both the Bio-Medical and Networking & Cyber division, and further strengthens our foundations. As a result, we remain very excited about our future and look forward to continuing to deliver shareholder value."

 

 

Enquiries:

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISSEIFWAEFSEDE
Date   Source Headline
11th Jun 201510:10 amRNSHolding(s) in Company
11th Jun 201510:07 amRNSHolding(s) in Company
27th May 20159:05 amRNSHolding(s) in Company
20th May 20157:00 amRNSDirector Shareholding
12th May 20157:01 amRNSTrading and Business Update
30th Apr 20153:07 pmRNSDirector/PDMR Shareholding
30th Apr 20151:57 pmRNSAnnual Financial Report
16th Apr 20151:41 pmRNSDirector/PDMR Shareholding
10th Mar 20157:02 amRNSPreliminary Results
5th Mar 20157:00 amRNSDe-listing from TASE
26th Feb 201511:41 amRNSNotice of Results
12th Feb 201512:03 pmRNSResult of EGM
2nd Feb 20157:00 amRNSDiagnostic Kit Granted Licence for Sale in China
26th Jan 20153:30 pmRNSDirector Declaration
21st Jan 20154:35 pmRNSNotice of EGM
6th Jan 20151:06 pmRNSDirector Share Purchase
15th Dec 20147:00 amRNSSenior Management Changes
11th Dec 20147:00 amRNSDirector/PDMR Shareholding
1st Dec 201410:03 amRNSHolding(s) in Company
18th Nov 20147:00 amRNSBATM awarded contract by major mobile operator
18th Nov 20147:00 amRNSBusiness Update and Appointment of Chairman
27th Oct 20147:00 amRNSBATM launches world's first 10GE platform
23rd Sep 20142:45 pmRNSTotal Voting Rights
22nd Sep 201412:30 pmRNSHolding(s) in Company
10th Sep 201411:40 amRNSResult of AGM
8th Sep 20147:00 amRNSBATM invests in Opticul Diagnostics
18th Aug 201412:58 pmRNSNotice of AGM
7th Aug 20147:00 amRNSInterim results
30th Jul 20147:00 amRNSNotification of Results
30th Jul 20147:00 amRNSCyber Security Agreement and Contract Win
16th Jun 20147:00 amRNSBATM wins two telecoms contracts in the US
28th May 20149:15 amRNSHolding(s) in Company
12th May 20147:00 amRNSBATM deploys surveillance solution in Islington
7th May 201412:25 pmRNSHolding(s) in Company
6th May 20147:01 amRNSInterim Management Statement
30th Apr 20141:22 pmRNSAnnual Financial Report
11th Apr 201410:45 amRNSHolding(s) in Company
7th Apr 201411:00 amRNSHolding(s) in Company
28th Mar 201411:00 amRNSHolding(s) in Company
12th Mar 20148:24 amRNSHolding(s) in Company
25th Feb 20147:00 amRNSPreliminary Results
17th Feb 20147:00 amRNSNotice of Results and Webcast
9th Jan 20144:15 pmRNSHolding(s) in Company
7th Jan 20147:00 amRNSTrading and Business Update
2nd Jan 201410:53 amRNSHolding(s) in Company
13th Dec 20134:30 pmRNSHolding(s) in Company
10th Dec 20135:10 pmRNSHolding(s) in Company
21st Nov 20138:30 amRNSHolding(s) in Company
20th Nov 20139:00 amRNSHolding(s) in Company
12th Nov 20137:00 amRNSBATM to join further Tel Aviv Stock Exchange index

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.